Papers by Deepak L. Bhatt
Page 6 · newest first
- Empagliflozin in Acute Myocardial Infarction in Patients with and Without Type 2 Diabetes: A Pre-Specified Analysis of the EMPACT-MI TrialEuropean Journal of Heart Failure · 2024
- Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Design of the EXCELLENT TrialESC Heart Failure · 2024
- Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous ThrombolysisJAMA Neurology · 2024
- Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionCirculation · 2024
- Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary SyndromesJAMA Cardiology · 2024
- Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational studyFrontiers in Pharmacology · 2024
- Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-AnalysisCirculation · 2024
- Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trialEuroIntervention · 2024
- Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular DiseaseStroke · 2024
- Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary SyndromeJournal of the American College of Cardiology · 2024
- O89 Pooled, Long-Term Analysis of the Global Symplicity Clinical Trial Program of Radiofrequency Renal Denervation for the Treatment of Uncontrolled HypertensionJournal of Hypertension · 2024
- Effects of Sotagliflozin on Health Status in Patients With Worsening Heart FailureJournal of the American College of Cardiology · 2024
- Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trialEuropean Heart Journal Open · 2024
- Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesEuropean Heart Journal · 2024
- Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesCirculation · 2024
- Valvular Heart Disease-Related Mortality Between Middle- and High-Income Countries During 2000 to 2019JACC Advances · 2024
- Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II TrialEuropean Heart Journal · 2024
- Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse populationnpj Digital Medicine · 2024
- Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for EvidenceJAMA · 2024
- Impact of gender in patients with device‐related thrombosis after left atrial appendage closure – A sub‐analysis from the multicenter EUROC‐DRT‐registryEchocardiography · 2024
- Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeCirculation · 2024
- Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) RegistryCardiovascular Diabetology · 2024
- Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During InflammationJournal of the American Heart Association · 2024
- Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trialsEuropean Heart Journal Open · 2024
- Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trialAlimentary Pharmacology & Therapeutics · 2024
- The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysisGlobal Cardiology · 2024
- Which Test Should I Order for an Inpatient Evaluation of Cardiac Ischemia?NEJM Evidence · 2024
- Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis2024
- 1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58Diabetes · 2024
- 522-P: Inhibition of Lipoprotein(a) [Lp(a)] Oxidation by Atorvastatin Active Hydroxylated Metabolites during High Glucose Compared with Rosuvastatin In VitroDiabetes · 2024
- 1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58Diabetes · 2024
- Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?European Heart Journal · 2024
- DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2024
- The Integration of Clinical Trials With the Practice of MedicineJAMA · 2024
- Impact of Frailty on the Benefits of Dual Pathway Inhibition for the Secondary Prevention of Cardiovascular Events in the COMPASS Randomised TrialCanadian Journal of Cardiology · 2024
- Procedural Volume and Outcomes in Lower Extremity Peripheral Vascular Interventions: Insights from the National Cardiovascular Data Registry Peripheral Vascular Intervention Registry2024
- Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping reviewEClinicalMedicine · 2024
- Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) RegistryJournal of the American Heart Association · 2024
- Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart FailureJACC Advances · 2024
- Moderate Aortic Valve Stenosis Is Associated With Increased Mortality Rate and Lifetime Loss: Systematic Review and Meta‐Analysis of Reconstructed Time‐to‐Event Data of 409 680 PatientsJournal of the American Heart Association · 2024
- Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trialEuroIntervention · 2024
- Pooled, Long-Term Analysis of the Global Symplicity Clinical Trial Program of Radiofrequency Renal Denervation for the Treatment of Uncontrolled HypertensionJournal of Hypertension · 2024
- One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesEuroIntervention · 2024
- Higher Baseline Systolic Blood Pressure Is Associated With Greater Blood Pressure Reductions Following Radiofrequency Renal Denervation in a Pooled Cohort of Over 3900 PatientsJournal of Hypertension · 2024
- C-44 | Identifying the Coronary Artery Calcium Score Threshold Indicative of Obstructive Coronary Artery DiseaseJournal of the Society for Cardiovascular Angiography & Interventions · 2024
- OR6-5 | Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction among United States HospitalsJournal of the Society for Cardiovascular Angiography & Interventions · 2024
- Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trialEP Europace · 2024
- The ROMA trial: 7 years of trial activities and the development of the ROMA trial networkEuropean Journal of Cardio-Thoracic Surgery · 2024
- Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-ITEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2024
- Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observationEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2024